Mangalam Drugs And Organics32.24
+0.00 (-1.29%)

Mangalam Drugs And Organics Share Price

32.24+0.00 (-1.29%)
-57.04% past 1 Year

Corporate filings & documents

Announcements

Subsequent Disclosure under Regulation 30 Para A of Schedule III of LODR 2015 for the bank default of the Company
1 week ago
Subsequent Disclosure under Regulation 30 Para A of Schedule III of LODR 2015 for the bank default of the Company
1 week ago
Disclosure under Regulation 30 of LODR 2015 for the appointment of Mr. Prabhakar Raghunath Zavar (DIN: 11940187) as the Additional Independent Director ( Non- Executive) for term of 5 years wef. 15/09/2026 at the Board Meeting held on today Tuesday September 15th 2026 subject to consent of Shareholders at the ensuing EGM.
1 week ago
Disclosure under Regulation 30 of LODR 2015 for the appointment of Mr. Prabhakar Raghunath Zavar (DIN: 11940187) as the Additional Independent Director ( Non- Executive) for term of 5 years wef. 15/09/2026 at the Board Meeting held on today Tuesday September 15th 2026 subject to consent of Shareholders at the ensuing EGM.
1 week ago
Outcome of Board Meeting pursuant to Regulation 30 of LODR for appointment of Mr. Prabhakar Raghunath Zavar as the Additional Indepedent Director ( Non- Executive) for term of 5 years wef. September 15th 2026 subject to consent of shareholders at ensuing EGM.
1 week ago
Outcome of Board Meeting pursuant to Regulation 30 of LODR for appointment of Mr. Prabhakar Raghunath Zavar as the Additional Indepedent Director ( Non- Executive) for term of 5 years wef. September 15th 2026 subject to consent of shareholders at ensuing EGM.
1 week ago
Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September 2026 and information on E-voting.
3 weeks ago
Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September 2026 and information on E-voting.
3 weeks ago
Intimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday September 23rd 2026 to the Shareholders of the Company.
3 weeks ago
Intimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday September 23rd 2026 to the Shareholders of the Company.
3 weeks ago
Annual Report of the Company Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday September 23rd 2026 and Intimation of Cut-off Date for remote E-voting of the Company.
3 weeks ago
Annual Report of the Company Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday September 23rd 2026 and Intimation of Cut-off Date for remote E-voting of the Company.
3 weeks ago
Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default
1 month ago
Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default
1 month ago
Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
1 month ago
Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
1 month ago
Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
1 month ago
Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
1 month ago
Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
1 month ago
Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
1 month ago
Declaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
1 month ago
Declaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
1 month ago
Outcome of Board meeting held on 12th August 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
1 month ago
Outcome of Board meeting held on 12th August 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
1 month ago
Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.
1 month ago
Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.
1 month ago
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.
1 month ago
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.
1 month ago
Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III
2 months ago
Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III
2 months ago
Intimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III
2 months ago
Intimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III
2 months ago
Intimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations 2018
2 months ago
Intimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations 2018
2 months ago
Intimation of closure of trading Window for the period ended 30th June 2026
2 months ago
Intimation of closure of trading Window for the period ended 30th June 2026
2 months ago
Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
3 months ago
Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
3 months ago
Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
3 months ago
Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
3 months ago
Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations 2015 of default of Bank Loan account.
3 months ago
Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations 2015 of default of Bank Loan account.
3 months ago
Submission of Annual Secretarial Compliance Report for the period ended 31st March 2026
4 months ago
Annual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.
4 months ago
Annual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.
4 months ago
Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.
4 months ago
Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.
4 months ago
Disclosure of notice of postal ballot /E- Voting seeking shareholders approval pursuant to Regulation 30 of SEBI LODR 2015 . for reappointment of Shri Praveen Saxena as an Independent Director DIN: 03199264 of the Company for second term of 5 consective years. The Evoting shall commence from 19.05.2026 (9:00 am) and will end on 17.06.2026 (5:00 pm).
4 months ago
Intimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default
4 months ago
Intimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default
4 months ago

Concalls & investor presentations

Empty box

No presentations found

Mangalam Drugs And Organics Ltd Share Price Today

The Mangalam Drugs And Organics Ltd share price today is ₹29.73. During the trading session, the Mangalam Drugs And Organics Ltd share price opened at ₹30.00 and recorded an intraday high of ₹30.43 and a low of ₹29.30. Last closing price was ₹30.02. Over the past 52 weeks, the Mangalam Drugs And Organics Ltd share price has ranged between ₹22.80 and ₹79.49. The current Mangalam Drugs And Organics Ltd stock price reflects real-time market activity based on executed trades on the exchange.